Development
HCA Healthcare, Inc.
HCA
$390.31
$7.401.93%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -22.78% | -4.85% | 3.29% | 7.07% | 14.72% |
| Total Depreciation and Amortization | 5.20% | 2.67% | 3.39% | 3.28% | 3.02% |
| Total Amortization of Deferred Charges | 28.57% | 28.57% | 0.00% | 28.57% | 16.67% |
| Total Other Non-Cash Items | 308.86% | -7.35% | -113.08% | 9.97% | 54.07% |
| Change in Net Operating Assets | -205.41% | -64.09% | 206.69% | 21.00% | -118.00% |
| Cash from Operations | 5.82% | -17.91% | 51.84% | 34.05% | 3.44% |
| Capital Expenditure | 12.40% | -1.41% | -14.91% | -39.02% | -10.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -637.50% | -161.67% | 92.11% | -5,650.00% | 92.22% |
| Divestitures | -98.29% | -98.26% | 16.67% | 1,078.57% | 225.00% |
| Other Investing Activities | -1,242.86% | -246.15% | 17.65% | -200.00% | 91.76% |
| Cash from Investing | -101.39% | -140.29% | -4.32% | -36.21% | 53.73% |
| Total Debt Issued | -97.16% | 100.22% | 112.69% | -79.22% | -93.83% |
| Total Debt Repaid | 4.60% | 207.32% | -1,316.67% | 80.67% | 312.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 40.09% | -63.32% | 65.88% | 59.73% | 26.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.56% | -1.25% | -2.50% | 1.13% | -5.41% |
| Other Financing Activities | 67.57% | 24.89% | -17.06% | 5.52% | -64.26% |
| Cash from Financing | 43.47% | 51.14% | 37.80% | -270.59% | -500.65% |
| Foreign Exchange rate Adjustments | -53.85% | 62.50% | 100.00% | 240.00% | 1,200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 148.35% | -79.43% | 101.32% | -107.17% | -121.46% |